BillionToOne drops after Fuzzy Panda discloses short position
BLLN•BillionToOne shares fell 7.6% after Fuzzy Panda disclosed a short position and alleged the company faces a Tennessee Medicaid fraud investigation and could face more than $1.2 billion in potential False Claims Act fines.
1. Short seller’s allegations
Fuzzy Panda alleged that BillionToOne faces an undisclosed Tennessee Medicaid fraud investigation over unnecessary testing and inflated reimbursements, and could face more than $1.2 billion in potential False Claims Act fines. The firm also alleged that BillionToOne caps patients’ out-of-pocket costs without verifying their income, citing former employees and recorded sales pitches. BillionToOne did not immediately respond to a request for comment.
2. Shares and analyst ratings
BillionToOne shares fell 7.6% shortly after the opening bell and briefly reached their lowest levels since May. Of eight brokerages covering the company, seven rated it “buy” or higher and one rated it “hold”; the median price target was $129.




